aldosterone has been researched along with quinocetone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Cheng, G; Dai, M; Guo, P; Ihsan, A; Liu, Z; Luo, X; Wang, X; Yang, C; Yuan, Z | 1 |
| Bai, Y; Chen, D; Cheng, G; Dai, M; Ihsan, A; Liu, Z; Tao, Y; Wang, X; Wang, Y; Yuan, Z; Zhu, F | 1 |
2 other study(ies) available for aldosterone and quinocetone
| Article | Year |
|---|---|
High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.
Topics: Adrenal Gland Diseases; Aldosterone; Antioxidants; Biotransformation; Cell Line; Cell Survival; Cytochrome P-450 CYP11B2; Humans; Oxidative Stress; Proanthocyanidins; Quinoxalines; RNA, Messenger; Steroid 11-beta-Hydroxylase | 2016 |
Genomic and proteomic analysis of the inhibition of synthesis and secretion of aldosterone hormone induced by quinocetone in NCI-H295R cells.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation; Genomics; Humans; Mass Spectrometry; Microarray Analysis; Oxidative Stress; Proteomics; Quinoxalines; Signal Transduction; Steroid 17-alpha-Hydroxylase | 2016 |